nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—AOX1—Methotrexate—ankylosing spondylitis	0.449	1	CbGbCtD
Brimonidine—Influenza—Triamcinolone—ankylosing spondylitis	0.0011	0.00199	CcSEcCtD
Brimonidine—Dry skin—Dexamethasone—ankylosing spondylitis	0.00106	0.00192	CcSEcCtD
Brimonidine—Dry skin—Betamethasone—ankylosing spondylitis	0.00106	0.00192	CcSEcCtD
Brimonidine—Coma—Methotrexate—ankylosing spondylitis	0.00105	0.00191	CcSEcCtD
Brimonidine—Bronchitis—Triamcinolone—ankylosing spondylitis	0.00105	0.00191	CcSEcCtD
Brimonidine—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00103	0.00188	CcSEcCtD
Brimonidine—Lethargy—Prednisone—ankylosing spondylitis	0.00102	0.00186	CcSEcCtD
Brimonidine—Osteoarthritis—Prednisone—ankylosing spondylitis	0.001	0.00182	CcSEcCtD
Brimonidine—Bradycardia—Prednisolone—ankylosing spondylitis	0.000972	0.00176	CcSEcCtD
Brimonidine—Face oedema—Prednisone—ankylosing spondylitis	0.000968	0.00176	CcSEcCtD
Brimonidine—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.000964	0.00175	CcSEcCtD
Brimonidine—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.000951	0.00172	CcSEcCtD
Brimonidine—Visual impairment—Prednisolone—ankylosing spondylitis	0.00092	0.00167	CcSEcCtD
Brimonidine—Dry skin—Prednisone—ankylosing spondylitis	0.000919	0.00167	CcSEcCtD
Brimonidine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000894	0.00162	CcSEcCtD
Brimonidine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000892	0.00162	CcSEcCtD
Brimonidine—Visual disturbance—Methotrexate—ankylosing spondylitis	0.000884	0.0016	CcSEcCtD
Brimonidine—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00088	0.0016	CcSEcCtD
Brimonidine—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.000878	0.00159	CcSEcCtD
Brimonidine—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.000871	0.00158	CcSEcCtD
Brimonidine—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000863	0.00157	CcSEcCtD
Brimonidine—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000863	0.00157	CcSEcCtD
Brimonidine—Lethargy—Methotrexate—ankylosing spondylitis	0.000855	0.00155	CcSEcCtD
Brimonidine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000853	0.00155	CcSEcCtD
Brimonidine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.000844	0.00153	CcSEcCtD
Brimonidine—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000838	0.00152	CcSEcCtD
Brimonidine—Erythema—Prednisolone—ankylosing spondylitis	0.000831	0.00151	CcSEcCtD
Brimonidine—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000819	0.00149	CcSEcCtD
Brimonidine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000813	0.00148	CcSEcCtD
Brimonidine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000811	0.00147	CcSEcCtD
Brimonidine—Bradycardia—Betamethasone—ankylosing spondylitis	0.000811	0.00147	CcSEcCtD
Brimonidine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000795	0.00144	CcSEcCtD
Brimonidine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000791	0.00144	CcSEcCtD
Brimonidine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000789	0.00143	CcSEcCtD
Brimonidine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000784	0.00142	CcSEcCtD
Brimonidine—Vision blurred—Prednisolone—ankylosing spondylitis	0.000783	0.00142	CcSEcCtD
Brimonidine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.000783	0.00142	CcSEcCtD
Brimonidine—Depression—Prednisone—ankylosing spondylitis	0.000771	0.0014	CcSEcCtD
Brimonidine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000768	0.00139	CcSEcCtD
Brimonidine—Visual impairment—Betamethasone—ankylosing spondylitis	0.000768	0.00139	CcSEcCtD
Brimonidine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000767	0.00139	CcSEcCtD
Brimonidine—Erythema—Triamcinolone—ankylosing spondylitis	0.000764	0.00139	CcSEcCtD
Brimonidine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000763	0.00138	CcSEcCtD
Brimonidine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000748	0.00136	CcSEcCtD
Brimonidine—Syncope—Prednisolone—ankylosing spondylitis	0.000745	0.00135	CcSEcCtD
Brimonidine—Eye disorder—Betamethasone—ankylosing spondylitis	0.000744	0.00135	CcSEcCtD
Brimonidine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000744	0.00135	CcSEcCtD
Brimonidine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00073	0.00133	CcSEcCtD
Brimonidine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000723	0.00131	CcSEcCtD
Brimonidine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000723	0.00131	CcSEcCtD
Brimonidine—Hypertension—Prednisolone—ankylosing spondylitis	0.000718	0.0013	CcSEcCtD
Brimonidine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000712	0.00129	CcSEcCtD
Brimonidine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000712	0.00129	CcSEcCtD
Brimonidine—Bradycardia—Prednisone—ankylosing spondylitis	0.000706	0.00128	CcSEcCtD
Brimonidine—Discomfort—Prednisolone—ankylosing spondylitis	0.000699	0.00127	CcSEcCtD
Brimonidine—Erythema—Betamethasone—ankylosing spondylitis	0.000693	0.00126	CcSEcCtD
Brimonidine—Erythema—Dexamethasone—ankylosing spondylitis	0.000693	0.00126	CcSEcCtD
Brimonidine—Syncope—Triamcinolone—ankylosing spondylitis	0.000685	0.00124	CcSEcCtD
Brimonidine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000684	0.00124	CcSEcCtD
Brimonidine—Oedema—Prednisolone—ankylosing spondylitis	0.000678	0.00123	CcSEcCtD
Brimonidine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000672	0.00122	CcSEcCtD
Brimonidine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00067	0.00122	CcSEcCtD
Brimonidine—Shock—Prednisolone—ankylosing spondylitis	0.000667	0.00121	CcSEcCtD
Brimonidine—Cough—Triamcinolone—ankylosing spondylitis	0.000667	0.00121	CcSEcCtD
Brimonidine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000662	0.0012	CcSEcCtD
Brimonidine—Hypertension—Triamcinolone—ankylosing spondylitis	0.00066	0.0012	CcSEcCtD
Brimonidine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000658	0.00119	CcSEcCtD
Brimonidine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000651	0.00118	CcSEcCtD
Brimonidine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000649	0.00118	CcSEcCtD
Brimonidine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000649	0.00118	CcSEcCtD
Brimonidine—Eye disorder—Prednisone—ankylosing spondylitis	0.000648	0.00118	CcSEcCtD
Brimonidine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000647	0.00117	CcSEcCtD
Brimonidine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000646	0.00117	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000645	0.00117	CcSEcCtD
Brimonidine—Depression—Methotrexate—ankylosing spondylitis	0.000644	0.00117	CcSEcCtD
Brimonidine—Flushing—Prednisone—ankylosing spondylitis	0.000644	0.00117	CcSEcCtD
Brimonidine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000643	0.00117	CcSEcCtD
Brimonidine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000641	0.00116	CcSEcCtD
Brimonidine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000636	0.00115	CcSEcCtD
Brimonidine—Angiopathy—Prednisone—ankylosing spondylitis	0.000629	0.00114	CcSEcCtD
Brimonidine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000628	0.00114	CcSEcCtD
Brimonidine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000627	0.00114	CcSEcCtD
Brimonidine—Oedema—Triamcinolone—ankylosing spondylitis	0.000624	0.00113	CcSEcCtD
Brimonidine—Syncope—Betamethasone—ankylosing spondylitis	0.000622	0.00113	CcSEcCtD
Brimonidine—Syncope—Dexamethasone—ankylosing spondylitis	0.000622	0.00113	CcSEcCtD
Brimonidine—Arrhythmia—Prednisone—ankylosing spondylitis	0.00062	0.00112	CcSEcCtD
Brimonidine—Infection—Triamcinolone—ankylosing spondylitis	0.00062	0.00112	CcSEcCtD
Brimonidine—Infection—Methylprednisolone—ankylosing spondylitis	0.000618	0.00112	CcSEcCtD
Brimonidine—Shock—Triamcinolone—ankylosing spondylitis	0.000614	0.00111	CcSEcCtD
Brimonidine—Insomnia—Prednisolone—ankylosing spondylitis	0.000613	0.00111	CcSEcCtD
Brimonidine—Shock—Methylprednisolone—ankylosing spondylitis	0.000612	0.00111	CcSEcCtD
Brimonidine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00061	0.00111	CcSEcCtD
Brimonidine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00061	0.00111	CcSEcCtD
Brimonidine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00061	0.00111	CcSEcCtD
Brimonidine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000609	0.00111	CcSEcCtD
Brimonidine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000609	0.0011	CcSEcCtD
Brimonidine—Mental disorder—Prednisone—ankylosing spondylitis	0.000608	0.0011	CcSEcCtD
Brimonidine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000607	0.0011	CcSEcCtD
Brimonidine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000605	0.0011	CcSEcCtD
Brimonidine—Erythema—Prednisone—ankylosing spondylitis	0.000604	0.0011	CcSEcCtD
Brimonidine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000599	0.00109	CcSEcCtD
Brimonidine—Hypertension—Betamethasone—ankylosing spondylitis	0.000599	0.00109	CcSEcCtD
Brimonidine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00059	0.00107	CcSEcCtD
Brimonidine—Myalgia—Betamethasone—ankylosing spondylitis	0.00059	0.00107	CcSEcCtD
Brimonidine—Anxiety—Betamethasone—ankylosing spondylitis	0.000588	0.00107	CcSEcCtD
Brimonidine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000588	0.00107	CcSEcCtD
Brimonidine—Discomfort—Betamethasone—ankylosing spondylitis	0.000583	0.00106	CcSEcCtD
Brimonidine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000583	0.00106	CcSEcCtD
Brimonidine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000582	0.00106	CcSEcCtD
Brimonidine—Pain—Prednisolone—ankylosing spondylitis	0.00058	0.00105	CcSEcCtD
Brimonidine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000575	0.00104	CcSEcCtD
Brimonidine—Vision blurred—Prednisone—ankylosing spondylitis	0.000569	0.00103	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000568	0.00103	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000567	0.00103	CcSEcCtD
Brimonidine—Oedema—Betamethasone—ankylosing spondylitis	0.000566	0.00103	CcSEcCtD
Brimonidine—Oedema—Dexamethasone—ankylosing spondylitis	0.000566	0.00103	CcSEcCtD
Brimonidine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000564	0.00102	CcSEcCtD
Brimonidine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000563	0.00102	CcSEcCtD
Brimonidine—Infection—Betamethasone—ankylosing spondylitis	0.000562	0.00102	CcSEcCtD
Brimonidine—Infection—Dexamethasone—ankylosing spondylitis	0.000562	0.00102	CcSEcCtD
Brimonidine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00056	0.00102	CcSEcCtD
Brimonidine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000559	0.00101	CcSEcCtD
Brimonidine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000559	0.00101	CcSEcCtD
Brimonidine—Shock—Betamethasone—ankylosing spondylitis	0.000557	0.00101	CcSEcCtD
Brimonidine—Shock—Dexamethasone—ankylosing spondylitis	0.000557	0.00101	CcSEcCtD
Brimonidine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000556	0.00101	CcSEcCtD
Brimonidine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000555	0.00101	CcSEcCtD
Brimonidine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000555	0.00101	CcSEcCtD
Brimonidine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000552	0.001	CcSEcCtD
Brimonidine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000552	0.001	CcSEcCtD
Brimonidine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000549	0.000996	CcSEcCtD
Brimonidine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000548	0.000994	CcSEcCtD
Brimonidine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000542	0.000983	CcSEcCtD
Brimonidine—Syncope—Prednisone—ankylosing spondylitis	0.000542	0.000983	CcSEcCtD
Brimonidine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000538	0.000976	CcSEcCtD
Brimonidine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000538	0.000976	CcSEcCtD
Brimonidine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000537	0.000974	CcSEcCtD
Brimonidine—Pain—Triamcinolone—ankylosing spondylitis	0.000533	0.000968	CcSEcCtD
Brimonidine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000531	0.000963	CcSEcCtD
Brimonidine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000529	0.00096	CcSEcCtD
Brimonidine—Hypotension—Betamethasone—ankylosing spondylitis	0.000529	0.00096	CcSEcCtD
Brimonidine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000526	0.000954	CcSEcCtD
Brimonidine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000524	0.00095	CcSEcCtD
Brimonidine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000523	0.000948	CcSEcCtD
Brimonidine—Hypertension—Prednisone—ankylosing spondylitis	0.000521	0.000946	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000516	0.000936	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000516	0.000936	CcSEcCtD
Brimonidine—Myalgia—Prednisone—ankylosing spondylitis	0.000514	0.000933	CcSEcCtD
Brimonidine—Arthralgia—Prednisone—ankylosing spondylitis	0.000514	0.000933	CcSEcCtD
Brimonidine—Anxiety—Prednisone—ankylosing spondylitis	0.000512	0.00093	CcSEcCtD
Brimonidine—Insomnia—Betamethasone—ankylosing spondylitis	0.000512	0.000929	CcSEcCtD
Brimonidine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000512	0.000929	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000511	0.000926	CcSEcCtD
Brimonidine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000508	0.000922	CcSEcCtD
Brimonidine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000508	0.000922	CcSEcCtD
Brimonidine—Discomfort—Prednisone—ankylosing spondylitis	0.000508	0.000922	CcSEcCtD
Brimonidine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000508	0.000922	CcSEcCtD
Brimonidine—Erythema—Methotrexate—ankylosing spondylitis	0.000505	0.000916	CcSEcCtD
Brimonidine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.0005	0.000907	CcSEcCtD
Brimonidine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000498	0.000904	CcSEcCtD
Brimonidine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000498	0.000904	CcSEcCtD
Brimonidine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000494	0.000897	CcSEcCtD
Brimonidine—Oedema—Prednisone—ankylosing spondylitis	0.000493	0.000894	CcSEcCtD
Brimonidine—Infection—Prednisone—ankylosing spondylitis	0.00049	0.000888	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000489	0.000887	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000489	0.000887	CcSEcCtD
Brimonidine—Fatigue—Betamethasone—ankylosing spondylitis	0.000488	0.000885	CcSEcCtD
Brimonidine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000488	0.000885	CcSEcCtD
Brimonidine—Shock—Prednisone—ankylosing spondylitis	0.000485	0.00088	CcSEcCtD
Brimonidine—Pain—Dexamethasone—ankylosing spondylitis	0.000484	0.000878	CcSEcCtD
Brimonidine—Pain—Betamethasone—ankylosing spondylitis	0.000484	0.000878	CcSEcCtD
Brimonidine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000483	0.000877	CcSEcCtD
Brimonidine—Tachycardia—Prednisone—ankylosing spondylitis	0.000481	0.000873	CcSEcCtD
Brimonidine—Skin disorder—Prednisone—ankylosing spondylitis	0.000479	0.000869	CcSEcCtD
Brimonidine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000476	0.000863	CcSEcCtD
Brimonidine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00046	0.000834	CcSEcCtD
Brimonidine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000459	0.000832	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000449	0.000815	CcSEcCtD
Brimonidine—Dizziness—Prednisolone—ankylosing spondylitis	0.000449	0.000814	CcSEcCtD
Brimonidine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000448	0.000812	CcSEcCtD
Brimonidine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000447	0.00081	CcSEcCtD
Brimonidine—Insomnia—Prednisone—ankylosing spondylitis	0.000446	0.000809	CcSEcCtD
Brimonidine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000443	0.000803	CcSEcCtD
Brimonidine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000441	0.000801	CcSEcCtD
Brimonidine—Cough—Methotrexate—ankylosing spondylitis	0.00044	0.000799	CcSEcCtD
Brimonidine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00044	0.000799	CcSEcCtD
Brimonidine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000434	0.000787	CcSEcCtD
Brimonidine—Myalgia—Methotrexate—ankylosing spondylitis	0.00043	0.00078	CcSEcCtD
Brimonidine—Chest pain—Methotrexate—ankylosing spondylitis	0.00043	0.00078	CcSEcCtD
Brimonidine—Arthralgia—Methotrexate—ankylosing spondylitis	0.00043	0.00078	CcSEcCtD
Brimonidine—Rash—Prednisolone—ankylosing spondylitis	0.000428	0.000776	CcSEcCtD
Brimonidine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000427	0.000775	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000427	0.000774	CcSEcCtD
Brimonidine—Fatigue—Prednisone—ankylosing spondylitis	0.000425	0.000771	CcSEcCtD
Brimonidine—Headache—Prednisolone—ankylosing spondylitis	0.000425	0.000771	CcSEcCtD
Brimonidine—Discomfort—Methotrexate—ankylosing spondylitis	0.000425	0.00077	CcSEcCtD
Brimonidine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000412	0.000748	CcSEcCtD
Brimonidine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000412	0.000747	CcSEcCtD
Brimonidine—Infection—Methotrexate—ankylosing spondylitis	0.000409	0.000742	CcSEcCtD
Brimonidine—Asthenia—Betamethasone—ankylosing spondylitis	0.000406	0.000737	CcSEcCtD
Brimonidine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000406	0.000737	CcSEcCtD
Brimonidine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000404	0.000733	CcSEcCtD
Brimonidine—Nausea—Prednisolone—ankylosing spondylitis	0.000403	0.000731	CcSEcCtD
Brimonidine—Pruritus—Betamethasone—ankylosing spondylitis	0.0004	0.000727	CcSEcCtD
Brimonidine—Pruritus—Dexamethasone—ankylosing spondylitis	0.0004	0.000727	CcSEcCtD
Brimonidine—Skin disorder—Methotrexate—ankylosing spondylitis	0.0004	0.000726	CcSEcCtD
Brimonidine—Rash—Triamcinolone—ankylosing spondylitis	0.000393	0.000714	CcSEcCtD
Brimonidine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000393	0.000713	CcSEcCtD
Brimonidine—Rash—Methylprednisolone—ankylosing spondylitis	0.000392	0.000712	CcSEcCtD
Brimonidine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000392	0.000711	CcSEcCtD
Brimonidine—Headache—Triamcinolone—ankylosing spondylitis	0.000391	0.000709	CcSEcCtD
Brimonidine—Headache—Methylprednisolone—ankylosing spondylitis	0.00039	0.000707	CcSEcCtD
Brimonidine—Hypotension—Methotrexate—ankylosing spondylitis	0.000385	0.000698	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000375	0.000681	CcSEcCtD
Brimonidine—Dizziness—Betamethasone—ankylosing spondylitis	0.000374	0.000679	CcSEcCtD
Brimonidine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000374	0.000679	CcSEcCtD
Brimonidine—Insomnia—Methotrexate—ankylosing spondylitis	0.000373	0.000676	CcSEcCtD
Brimonidine—Nausea—Triamcinolone—ankylosing spondylitis	0.000371	0.000672	CcSEcCtD
Brimonidine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00037	0.000671	CcSEcCtD
Brimonidine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00037	0.000671	CcSEcCtD
Brimonidine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000367	0.000666	CcSEcCtD
Brimonidine—Somnolence—Methotrexate—ankylosing spondylitis	0.000366	0.000664	CcSEcCtD
Brimonidine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000363	0.000659	CcSEcCtD
Brimonidine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000363	0.000658	CcSEcCtD
Brimonidine—Rash—Betamethasone—ankylosing spondylitis	0.000357	0.000647	CcSEcCtD
Brimonidine—Rash—Dexamethasone—ankylosing spondylitis	0.000357	0.000647	CcSEcCtD
Brimonidine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000357	0.000647	CcSEcCtD
Brimonidine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000357	0.000647	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000356	0.000645	CcSEcCtD
Brimonidine—Fatigue—Methotrexate—ankylosing spondylitis	0.000355	0.000644	CcSEcCtD
Brimonidine—Headache—Betamethasone—ankylosing spondylitis	0.000355	0.000643	CcSEcCtD
Brimonidine—Headache—Dexamethasone—ankylosing spondylitis	0.000355	0.000643	CcSEcCtD
Brimonidine—Asthenia—Prednisone—ankylosing spondylitis	0.000354	0.000642	CcSEcCtD
Brimonidine—Pain—Methotrexate—ankylosing spondylitis	0.000352	0.000639	CcSEcCtD
Brimonidine—Pruritus—Prednisone—ankylosing spondylitis	0.000349	0.000633	CcSEcCtD
Brimonidine—Nausea—Dexamethasone—ankylosing spondylitis	0.000336	0.00061	CcSEcCtD
Brimonidine—Nausea—Betamethasone—ankylosing spondylitis	0.000336	0.00061	CcSEcCtD
Brimonidine—Dizziness—Prednisone—ankylosing spondylitis	0.000326	0.000591	CcSEcCtD
Brimonidine—Rash—Prednisone—ankylosing spondylitis	0.000311	0.000564	CcSEcCtD
Brimonidine—Dermatitis—Prednisone—ankylosing spondylitis	0.00031	0.000563	CcSEcCtD
Brimonidine—Headache—Prednisone—ankylosing spondylitis	0.000309	0.00056	CcSEcCtD
Brimonidine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000303	0.000551	CcSEcCtD
Brimonidine—Asthenia—Methotrexate—ankylosing spondylitis	0.000296	0.000536	CcSEcCtD
Brimonidine—Nausea—Prednisone—ankylosing spondylitis	0.000293	0.000531	CcSEcCtD
Brimonidine—Pruritus—Methotrexate—ankylosing spondylitis	0.000291	0.000529	CcSEcCtD
Brimonidine—Dizziness—Methotrexate—ankylosing spondylitis	0.000272	0.000494	CcSEcCtD
Brimonidine—Rash—Methotrexate—ankylosing spondylitis	0.00026	0.000471	CcSEcCtD
Brimonidine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000259	0.000471	CcSEcCtD
Brimonidine—Headache—Methotrexate—ankylosing spondylitis	0.000258	0.000468	CcSEcCtD
Brimonidine—Nausea—Methotrexate—ankylosing spondylitis	0.000245	0.000444	CcSEcCtD
